3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
1
Hypoxia
1
Head and Neck Neoplasms
1
Interventions
Cisplatin
22
Radiotherapy
15
Cetuximab
12
Docetaxel
11
Carboplatin
10
pembrolizumab
8
toripalimab
6
camrelizumab
6
Paclitaxel
5
Nivolumab
5
Neoadjuvant Therapy
5
Fluorouracil
5
Drug Therapy
5
Chemoradiotherapy
5
nimotuzumab
4
durvalumab
4
Blood Specimen Collection
4
sintilimab
3
cemiplimab
3
apatinib
3
advexin
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Immunohistochemistry
3
Celecoxib
3
nedaplatin
2
Therapeutics
2
Tegafur
2
Radiotherapy, Intensity-Modulated
2
Methotrexate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Squamous Cell Carcinoma of Head and Neck
×
Nimorazole
×
Clear all
NCT02661152
2021-04-13
DAHANCA30
Danish Head and Neck Cancer Group
Phase 3
Unknown
1,252 enrolled